CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Boule Diagnostics AB Company Snapshot
Boule Diagnostics AB operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Boule Diagnostics AB with three other companies in this sector in Sweden: Arcoma AB (2016 sales of 102.08 million Swedish Kronor [US$12.29 million] ), Cellavision AB (265.04 million Swedish Kronor [US$31.92 million] of which 100% was Automatic Microscopy), and Biotage AB (667.91 million Swedish Kronor [US$80.43 million] of which 100% was Royalty-Based Payme).

Sales Analysis. Boule Diagnostics AB reported sales of SEK 400.74 million (US$48.26 million) for the year ending December of 2016. This represents an increase of 20.9% versus 2015, when the company's sales were SEK 331.41 million. Sales at Boule Diagnostics AB have increased during each of the previous five years (and since 2011, sales have increased a total of 63%). Sales of Instruments saw an increase of 30.8% in 2016, from SEK 119.00 million to SEK 155.70 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Boule Diagnostics AB
  Stock Performance Chart for Boule Diagnostics AB
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 285.00
(Figures in Swedish Kronor)
1 Week -3.1%   13 Weeks -11.8%  
4 Weeks 15.4%   52 Weeks 214.0%  
 
Boule Diagnostics AB Key Data:
  Ticker: BOUL Country: Sweden
  Exchanges: STO Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2016 Sales 400,735,000
(Year Ending Jan 2017).
Employees: 169
  Currency: Swedish Kronor Market Cap: 1,341,534,330
  Fiscal Yr Ends: December Shares Outstanding: 4,707,138
  Share Type: Ordinary Closely Held Shares: 1,529,534
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.